在疹神经疼痛中S100A8/A9:分子机制和治疗前景
Dongzhi Jiang1, Ziyuan Zhang2, Fei Ren3
1Department of Anesthesiology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan, China.
Frontiers in immunology
|July 21, 2025
概括
带状疹 (疹) 中的关键分子S100A8/A9通过引起神经炎症来驱动慢性疼痛. 准这种分子为治疗神经病痛和相关神经系统疾病提供了一条新的途径.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 由VZV重新激活引起的疹疹 (HZ),通常导致具有挑战性的疹后神经痛 (PHN).
- 了解慢性疼痛过渡的分子基础对于有效治疗至关重要.
研究的目的:
- 阐明S100A8/A9,一种与损伤相关的分子模式 (DAMP) 在与HZ相关的神经病变疼痛的发病过程中的作用.
- 探索S100A8 / A9作为慢性疼痛的潜在治疗点.
主要方法:
- 对分子机制的系统分析.
- 审查新兴技术,如单细胞测序和多omics.
- 分子,细胞和临床数据的整合.
主要成果:
- S100A8/A9通过通过TLR4/TNF信号调节神经炎症,在HZ相关的神经病痛中发挥关键作用.
- 这种蛋白质复合物破坏神经元的平衡,导致疼痛慢性化.
- 先进的技术提高了对这些分子动态的理解.
结论:
- S100A8/A9在疹中转化为慢性疼痛的一个重要因素.
- 针对S100A8/A9是一个有前途的治疗策略,用于神经病痛.
- 对HZ诱导的疼痛需要个性化干预,S100A8 / A9作为潜在的生物标志物.
关键词:
S100A8 / A9 / A9 / S100A8 / A9 / S100A8 / A9 / S100A8 / A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A8 / S100A8 / S100A9 / S100A9 / S100A8 / S100A9 / S100A8 / S100A9 / S100A8 / S100A9 / S100A8 / S100A9 / S100A9 / S100A8 / S100A8 / S100A8 / S100A8 / S100A9疹子 疹子神经炎症是一种神经炎症.疼痛的转化 疼痛的转化术后性神经疼痛 术后性神经痛相关概念视频
Local Anesthetics: Differential Sensitivity of Nerve Fibers
938
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
938
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
454
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
454
Local Anesthetics: Mechanism of Action
2.5K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.5K
Local Anesthetics: Clinical Application as Spinal Anesthesia
796
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
796
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
1.2K
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
1.2K


